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Loss of kidney function in renal ischemia/reperfusion injury
is due to programmed cell death, but the contribution
of necroptosis, a newly discovered form of programmed
necrosis, has not been evaluated. Here, we identified the
presence of death receptor–mediated but caspase-
independent cell death in murine tubular cells and
characterized it as necroptosis by the addition of
necrostatin-1, a highly specific receptor-interacting protein
kinase 1 inhibitor. The detection of receptor-interacting
protein kinase 1 and 3 in whole-kidney lysates and freshly
isolated murine proximal tubules led us to investigate the
contribution of necroptosis in a mouse model of renal
ischemia/reperfusion injury. Treatment with necrostatin-1
reduced organ damage and renal failure, even when
administered after reperfusion, resulting in a significant
survival benefit in a model of lethal renal ischemia/
reperfusion injury. Unexpectedly, specific blockade of
apoptosis by zVAD, a pan-caspase inhibitor, did not
prevent the organ damage or the increase in urea and
creatinine in vivo in renal ischemia/reperfusion injury.
Thus, necroptosis is present and has functional relevance
in the pathophysiological course of ischemic kidney injury
and shows the predominance of necroptosis over apoptosis
in this setting. Necrostatin-1 may have therapeutic potential
to prevent and treat renal ischemia/reperfusion injury.
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Programmed cell death (PCD) was initially used synony-
mously with apoptosis until caspase-independent cell death
(CICD) was discovered.1,2 Cell shrinkage, chromatin con-
densation, membrane blebbing, and nuclear fragmentation
are due to the proteolytic activity of caspases and define
the characteristics of apoptosis2 mediated via the extrinsic or
the intrinsic apoptotic pathway.3,4 The receptor-mediated
extrinsic pathway involves the assembly of the death-
inducing signaling complex, which includes death receptors
(e.g., tumor necrosis factor receptor (TNFR), Fas), the
adapter protein Fas-associated death domain, and the initi-
ator caspase-8 that subsequently cleaves the effector caspase-3
to execute the apoptosis.5 The intrinsic apoptotic pathway
involves cytochrome c release from mitochondria,5,6 which
results in the assembly of the caspase-9-containing apopto-
some, which, similar to caspase-8, activates caspase-3.7 The
apoptotic cascade is involved in innate immune responses
targeting virally infected cells.3 Consequently, viruses express
caspase inhibitors such as the baculovirus protein p35 or
the cowpox virus protein crmA.8,9 Loss of caspase-8 or Fas-
associated death domain, and also inhibition of caspase-8 by
the pan-caspase inhibitor zVAD or viral proteins, results in
necroptosis, which is a specific subform of programmed
necrosis. Programmed necrosis encompasses different signal-
ing pathways other than necroptosis, e.g., programmed
necrosis mediated by lysosomal membrane peroxidation or
the release of necrosis-inducing factors after mitochondrial
permeability transition (MPT).10–12 Execution of necroptosis
requires the assembly of the receptor-interacting protein
kinase (RIP)1- and/or RIP3-containing necroptosome.13–16
Other authors define necroptosis as CICD with a necrotic
phenotype that can be prevented by the highly specific Rip1
inhibitor necrostatin-1 (Nec-1).17,18 In this article, we use the
latter definition of necroptosis.
Physiologically relevant necroptosis has been demon-
strated to occur in T lymphocytes,19,20 photoreceptors,21 a
stroke model,22 and has been suggested to contribute to the
pathogenesis of myocardial infarction.23 In addition, it has
been interpreted as a second-line defense mechanism against
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viruses because infection with a sublethal dose of vaccinia
virus led to 100% lethality of RIP3-deficient mice.10 Impor-
tantly, the lethal phenotype of caspase-8-deficient mice24 was
recently demonstrated to be mediated via the necroptosome,
further underlining both the in vivo relevance and the current
concept of necroptosis.25,26 In line with this report, condi-
tional targeting of Fas-associated death domain in gastro-
intestinal epithelial cells causes severe colitis, a phenotype
that can be reversed on a RIP3-deficient background.27
In renal ischemia/reperfusion (IR) models, a multiplicity
of studies have investigated the influence of defined
components of the machinery involved in PCD.28 Lympho-
cytes, natural killer cells, and macrophages have been
demonstrated to significantly contribute to tubular cell
PCD.29–32 Conflicting results exist with regard to the
influence of members of the TNF superfamily. Although
Fas-mutated lpr mice are protected from renal IR injury
(IRI),33,34 the protective trend in immunodeficient mice
that were adoptively transferred with natural killer cells
taken from Fas ligand (FasL)–mutated gld mice did not reach
statistical significance.29 In contrast, one recent report
demonstrated a protective effect in gld mice with renal
IRI.35 Importantly, both TNF-a and FasL are capable of
inducing necroptosis in vivo,25,26 suggesting that the studies
on gld or lpr mice and TNFR mutants do not provide a tool
to discriminate between apoptosis and necroptosis.
Here we demonstrate the functional relevance of necrop-
tosis in the kidney. Importantly, in comparison with zVAD
treatment, the protective effect of Nec-1 was more pro-
nounced, which suggests for a functional predominance
of necroptosis over apoptosis in the pathophysiology of
renal IRI.
RESULTS
Renal tubular cells are insensitive to Fas- or TNF-a-mediated
apoptosis
We investigated the mechanisms of PCD in the murine
tubular cell line TKPTS. As demonstrated in Figure 1a,
incubation with vehicle, 100 ng/ml TNF-a, or activating
a-Fas monoclonal antibodies did not cause significant
cell death as detected by annexin V positivity after 24 h of
incubation at 371C. For comparison, Jurkat cells, a T-cell line
sensitive for Fas-mediated apoptosis, were stimulated for 5 h
at 371C with the indicated reagents.
Renal tubular cells are sensitive to TNFa/cycloheximide
(CHX)-mediated CICD
Induction of TNF-a-mediated apoptosis requires the addi-
tional application of CHX in some cells.1 We added 2mg/ml
CHX to TNF-a-treated TKPTS cells and investigated annexin
V positivity 24 h later (Figure 1b). Again, Jurkat T cells are
depicted for comparison. Although the addition of the
pan-caspase inhibitor zVAD prevented caspase-dependent,
TNF-a/CHX-induced apoptotic cell death in Jurkat cells, no
reduction of annexin V positivity was measured in TKPTS
cells.
TNF-a-mediated necroptosis in the renal proximal tubular
(prox. tubule) cell line TKPTS is mediated by Rip1
To further classify the CICD that TKPTS cells undergo in
Figure 1b, we investigated the recently described necroptosis
pathway.14,16 Annexin V positivity is an established readout
for both apoptotic and necroptotic cell death and allows to
distinguish between apoptosis, programmed necrosis, and
necroptosis only through the addition of zVAD and Nec-1.13
Classical assays for necroptosis include the stimulation of
cells with a combination of TNF-a, CHX, and zVAD (herein
denoted as TCZ).10 Annexin V positivity increased from
2.07% in the vehicle-treated cells to 20.19% in the TCZ-
stimulated cells. The significant decrease in annexin V
positivity upon additional treatment with Nec-1 (9.11%,
Po0.05) defines this subform of CICD as Rip1-dependent
necroptosis (Figure 2b). For comparison, similar experiments
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Figure 1 |TKPTS cells are insensitive to death
receptor–mediated apoptosis and sensitive to death
receptor–mediated caspase-independent cell death (CICD).
(a) Jurkat T cells and TKPTS cells were treated with vehicle,
activating a-Fas monoclonal antibodies, or tumor necrosis factor
alpha (TNF-a) for 5 h, as indicated. Positivity for annexin V
was detected by fluorescence-activated cell sorting analysis.
(b) Jurkat T cells and TKPTS cells were treated with vehicle or
TNF-aþ cycloheximide (CHX) in the presence or absence of the
pan-caspase inhibitor zVAD and stained for annexin V positivity
after 5 or 24 h, respectively.
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using HT29 cells, a necroptosis-sensitive cell line,11 are shown
(Figure 2a). Experiments were repeated four times. To further
specify the dependence of necroptosis on Rip1, we co-
incubated TKPTS cells with Rip1-specific siRNA for 48 h
before TCZ treatment. As demonstrated in Supplementary
Figure S1 online, knockdown of Rip1 reduced necroptosis in
this setting. However, we were unable to co-precipitate Rip1
and Rip3 in these cells. To exclude the presence of apoptosis,
we stimulated TKPTS cells with a combination of TNF-a, CHX,
and zVAD, and investigated the presence of cleaved caspase-3
and compared those with Jurkat cells. Supplementary Figure S2
online demonstrates the absence of caspase-3 activation in
TKPTS cells after 4 or 24 h. Taken together, these results provide
the first evidence of necroptosis in kidney cells.
In contrast to murine mesangial cells, murine glomerular
endothelial cells are sensitive to TNF-a-mediated necroptosis
To evaluate the susceptibility of other kidney cells to undergo
necroptosis, we investigated Rip1 and Rip3 expression levels
in the murine glomerular endothelial cell line glENDp54 and
the murine mesangial cell line MMC. For comparison, the
commonly used necroptosis-sensitive cell line L929 (murine
fibroblasts) was investigated. Rip1 and Rip3 were detected in
all of these cell lines, although RIP3 expression in MMCs was
significantly lower than in the glENDp54 and L929 cells.
Detection of b-actin served as a loading control (Figure 3a).
Sensitivity to necroptosis was further tested by stimulation of
each cell line with TCZ and TCZþNec-1 as indicated (Figure
3b), after treatment for 24 h in the case of MMCs and glENDs
and 5 h in the case of L929 cells. Although cell death in MMCs
was not induced upon stimulation with TCZ, glENDs showed
a delayed similar reaction pattern when compared with L929
cells after TCZ stimulation. The CICD in L929 cells and glENDs
can be defined as necroptosis because of the significant reduction
upon addition of Nec-1. In addition, we knocked down RIP3 by
siRNA 48h before CICD and demonstrated the protection from
necroptosis in glENDs (Supplementary Figure S3 online). To
analyze the PCD susceptibility of podocytes, we analyzed PCD in
a widely used human podocyte cell line. Upon stimulation with
either vehicle, TNF-a, TNFa/CHX, and TNF-a/CHX/zVAD for
24 h, no significant induction of annexin V positivity was
observed (Supplementary Figure S4 online).
Detection of Rip1 and Rip3 expression in freshly isolated
kidney tissues
To investigate the in vivo presence of the molecular
machinery that has been demonstrated to be required for
the execution of necroptosis, we generated lysates of homo-
genized murine whole-kidney tissue, freshly isolated thick
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Figure 2 | Tumor necrosis factor alpha (TNF-a)-mediated
necroptosis in TKPTS cells is prevented by the addition of
necrostatin-1 (Nec-1). (a) Caspase-independent cell death of
HT29 cells (positive control) was induced by the combined
treatment of TNF-a/cycloheximide (CHX)/zVAD (TCZ) for 5 h and
identified as necroptosis by the lack of annexin V positivity in the
presence of the specific receptor-interacting protein kinase 1
(Rip1) inhibitor Nec-1 (Po0.05). (b) TKPTS cells were treated as
described in Figure 1a for 24 h, and annexin V positivity was
determined by fluorescence-activated cell sorting analysis. Four
independent experiments were conducted. *Po0.05.
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Figure 3 | In contrast to the murine mesangial cell line MMC,
the glomerular endothelial cell line glEND is susceptible to
necroptosis. (a) Lysates prepared from the murine standard
necroptosis-sensitive cell line L929 (fibroblasts), the glomerular
endothelial cell line glEND, and the murine mesangial cell line
MMC were analyzed for the expression of receptor-interacting
protein kinase 1 (RIP)1 and RIP3. Expression of b-actin served as a
loading control. (b) The abovementioned cell lines were cultivated
for 4 h (L929) or 24 h in the presence or absence of tumor necrosis
factor alpha (TNF-a)/cycloheximide (CHX)/zVAD (TCZ) and
necrostatin-1 (Nec-1) as indicated. Similar to L929 cells, glEND cells
were susceptible to necroptosis, whereas MMCs were not. Data
from three independent experiments are shown. *Po0.05.
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ascending limb segments, and freshly isolated renal proximal
tubules (prox. tubules). Western blot analyses using anti-
bodies against Rip1 and Rip3 were performed to demonstrate
protein expression levels (Figure 4a). Note that the thick
ascending limb lane was loaded with 8 mg protein, whereas
the whole kidney and the prox. tubule lanes each were loaded
with 40 mg protein. In kidney slices taken from untreated
mice, immunohistochemistry-based determination of basal
levels of Rip1 was performed (Figure 4b) as recently
described.36 Cytosolic expression of Rip1 was located toward
the basolateral compartment of tubular cells. In addition,
Rip1 expression was found close to the brush border.
Adequate antibodies for immunohistochemical detection of
murine RIP3 have not been established to our knowledge.
Inhibition of Rip1-mediated necroptosis by necrostatin-1
protects from renal ischemia/reperfusion injury
To evaluate the functional relevance of Rip1-mediated
necroptotic cell death in an appropriate in vivo model of
acute renal failure, we used the well-established renal IR
model. Six- to eight-week-old male C57BL/6N mice under-
went bilateral renal pedicle clamping for 30min, followed by
48 h of reperfusion. Mice were left untreated, underwent
sham, or IR surgery, and received 200 ml phosphate-buffered
saline or 1.65mg Nec-1/kg body weight in a total volume of
200 ml intraperitoneally at 15min before the onset of
ischemia. Kidneys were harvested for histological evaluation,
and blood samples were used for the determination of serum
concentrations of urea and creatinine. Periodic acid–Schiff
staining was performed, and a renal damage score was used,
as previously published.37 Representative kidney sections are
shown in Figure 5a, and results of the evaluation of the renal
damage score are shown in Figure 5b. Marked reduction of
renal damage was achieved by a single application of Nec-1
(Po0.05). Electron microscopy detected necrotic cells in
renal tubules from untreated, sham-operated, and IR-treated
mice in the presence or absence of Nec-1. Representative
sections are depicted in Figure 5c. Hallmarks of necrotic cell
death such as nuclear swelling, loss of mitochondria, and loss
of cell organelle content predominantly appeared in the
IR-treated group (Supplementary Figure S5 online). Typical
hallmarks of apoptotic cell death such as blebbing and
shrinkage of cells have not been detected. As demonstrated in
Figure 5d and e, in untreated or sham-operated mice that were
followed up for 48 h of reperfusion, the basal serum urea levels
were at 44.25±5.7mg/dl. The basal levels of serum creatinine
values did not exceed 0.11mg/dl (0.10±0.01mg/dl). As
expected, IR-treated mice showed increased blood levels of
urea and creatinine at that time point, but also 24 and 72h
after reperfusion. Statistically significant reduction of serum
urea and serum creatinine levels was detected at all of
these three time points after reperfusion. To further confirm
the specificity of Nec-1 to interfere with Rip1, we used
an inactive derivative of necrostatin-1 (Nec-1i) that did not
influence serum concentrations of urea and creatinine
(Supplementary Figure S6 online). These experiments
provide the first evidence for the presence of necroptosis in
a pathophysiologically relevant process in the kidney.
Therapeutical potential of necrostatin-1 in renal
ischemia–reperfusion
To further characterize the time course of necroptosis in renal
IRI, we investigated the therapeutical potential of Nec-1
when applied 15min after reperfusion. Thus, mice under-
went IR surgery for 30min without preoperative injections
but were injected with 200 ml phosphate-buffered saline or an
equal volume containing 1.65mg Nec-1/kg body weight
15min after reperfusion. After 48 h, the mice were killed,
blood samples were taken, and kidneys were harvested for
histological evaluation. Representative kidney sections are
demonstrated in Figure 6a, and a quantification of renal
damage is shown in Figure 6b. The reduction of renal damage
by Nec-1 15min after reperfusion was comparable to the
results obtained with Nec-1 pretreatment (Figure 5b) before
the onset of ischemia (Po0.05). Nec-1 induced a significant
reduction in serum creatinine values (Figure 6d, Po0.05),
but the reduction of serum urea levels did not reach statistical
significance (Figure 6c). However, urea levels were not
significantly different from those obtained with Nec-1
treatment before pedicle clipping (Figure 5d). In a separate
experiment, a high-dose application of Nec-1 was investigated
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Figure 4 |Detection of the protein machinery required for
necroptosis in renal tubular cells. (a) Protein expression
of the necroptosis key factors Rip1 (receptor-interacting protein
kinase 1) and RIP3 was detected in lysates prepared from
whole-untreated murine kidneys, freshly isolated renal thick
ascending limb segments (TALs), or freshly isolated proximal
tubules (prox. tubules), as indicated. (b) Detection of Rip1 by
immunohistochemistry in kidney sections of an untreated C57BL/
6N mouse in the basolateral tubular compartment and in the
brush border of tubular cells. Bar¼ 20 mm.
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Figure 5 |Necroptosis essentially contributes to renal ischemia/reperfusion injury in vivo. Six- to eight-week-old male C57BL/6N mice
were treated with a 200 ml total volume of phosphate-buffered saline or necrostatin-1 (Nec-1) 15min before sham surgery or bilateral renal
pedicle clipping for 30min, followed by 48 h of reperfusion, as indicated. (a) Representative Periodic acid–Schiff-stained kidney sections
are illustrated. (b) Quantification of the renal tubular damage is demonstrated for whole kidneys (black bars), the outer renal cortex
(white bars), and the medullary cortex (gray bars). Bar¼ 20mm. (c) Representative electron micrographs of necrotic proximal renal tubule
(prox. tubule) cells are shown. Note the prominent nuclear swelling, loss of nuclear condensation, and loss of mitochondrial and
endoplasmatic reticulum mass as hallmarks of programmed necrosis. Bar¼ 2 mm. For each of the abovementioned groups, and for
completely independent groups that have been analyzed 24 and 72 h after reperfusion, respectively, serum concentrations of urea (d) and
creatinine (e) are depicted (P-values are: *o0.05, **o0.01).
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Figure 6 | Therapeutical potential of necrostatin-1 in renal ischemia/reperfusion injury (IRI). Six- to eight-week-old male C57BL/6N
mice were left untreated or underwent sham surgery or 30min of bilateral renal pedicle clipping, followed by 48 h of reperfusion with or
without the application of 200 ml phosphate-buffered saline or therapeutical necrostatin-1 (Nec-1) (th. Nec-1) 15min after reperfusion, as
indicated. (a) Representative periodic acid–Schiff-stained kidney sections are shown. Bar¼ 20mm. (b) Renal tubular damage scores of these
organs were quantified. Levels of urea and creatinine were determined in serum samples taken at 48 h after reperfusion and are depicted in
c and d, respectively (n¼ 8 for each group). In a separate experiment, multiple doses of Nec-1 (four applications within 240min after
reperfusion, see text for details) did not provide an additional protective effect on serum concentrations of urea (e) or creatinine (f) (n¼ 5
for each group) when compared with Figure 5. (g) In a model of lethal renal IRI (40min of bilateral pedicle clamping), mice received either
two injections of 200 ml phosphate-buffered saline (black squares) or two applications of 1.65mg Nec-1/kg body weight (white squares)
intraperitoneally, 15min before ischemia and 15min after reperfusion. Survival statistics are demonstrated in a Kaplan–Meier plot (n¼ 10 for
each group, Po0.01). *Po0.05.
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for putatively additive effects. Mice received injections of
1.65mg Nec-1/kg body weight for four times (15min before
ischemia and 15, 120, and 240min after reperfusion). As
demonstrated in Figure 6e and f, no additive protective effect
was observed for multiple doses of Nec-1 when compared
with the data from Figure 5d and e.
Necrostatin-1 prolongs survival after otherwise lethal renal
ischemia/reperfusion injury
To further analyze the potency of Nec-1 in reducing renal IRI,
we challenged the Rip1 inhibitor in a 40-min bilateral
clipping model of renal ischemia that is characterized by high
mortality in C57BL/6N mice. As demonstrated in Figure 6g,
two applications of 1.65mg Nec-1/kg body weight in 200 ml
total volume that were applied 15min before ischemia onset
and 15min after the onset of reperfusion led to a significant
difference in overall survival when compared with phos-
phate-buffered saline-treated mice in this model (Po0.05,
n¼ 10).
Renal IRI pathophysiologically occurs predominantly through
necroptosis rather than apoptosis
Because the blockade of apoptosis with the pan-caspase
inhibitor zVAD has been suggested to prevent renal injury
after IR,38 and because we wanted to understand the
contribution of each single PCD component in this setting,
we investigated the effects of blocking apoptosis and
necroptosis. We therefore compared the amount of protec-
tion detected in Nec-1-treated mice (the experimental setup
was described in Figure 5) with an additional group that was
treated with 10mg zVAD/kg body weight in an equal final
volume of 200 ml 15min before the induction of ischemia.
Representative Periodic acid–Schiff-stained kidney sections
taken 48 h after reperfusion are demonstrated for untreated,
IR, IRþNec-1, and IRþ zVAD groups in Figure 7a, and a
quantification of renal damage is depicted in Figure 7b.
Interestingly, in the zVAD-treated group, no reduction of
serum urea levels was detected, and the reducing trend in
serum creatinine levels did not reach statistical significance
(Figure 7c and d). Consistent with the high numbers of
necrotic tubular cells, we concluded that necroptosis, rather
than apoptosis, accounts for significant tubular damage in
renal IRI.
DISCUSSION
Changes in histomicrographs taken of kidneys after acute
renal IRI were specified by pathologists as acute tubular
necrosis for years before the first description of apoptosis in
renal IRI in 1992.39 Since then, among nephrologists, a
dogma developed that presumes that the genetically pro-
grammed and putatively therapeutically alterable fraction of
cells that undergo PCD in renal IRI is limited to apoptotic
cells. Extrinsic apoptosis has been established to be initiated
by death receptors that are members of the TNFR super-
family of transmembrane proteins,3,40 and various reports
discussed the in vivo relevance of TNFR family members in
the kidney.34,37 Because recent data substantially contributed
to our understanding of the regulation of the molecular
machinery involved in signaling events downstream of the
TNFR and Fas, it has become clear that either apoptosis or
necroptosis can be initiated by these receptors, depending on
the intracellular status of the target cell. In the presence of an
active caspase-8/FLIPL heterodimer, Rip1 is inactivated and
necroptotic signaling is prevented.26,41 If any single compo-
nent of this heterodimer is lacking, uncleaved Rip1 will
initiate the assembly of the necroptosome, which is believed
to be responsible for the execution of necroptosis.13,14,42
Therefore, previously conducted studies on lpr- or gld-
mice33,35 will not allow extrinsic apoptosis to be differen-
tiated from necroptosis. Given these data and the finding that
TNFR1-deficient mice are not protected from renal IRI,43 we
question the evidence for the functional contribution of
apoptosis in this setting. Caspase-8-deficient mice are not
viable,24 and therefore cannot contribute to answering this
question. Similarly, caspase-3 deficiency leads to early death
of the mice at the age of 1 to 3 weeks.44 Fas-associated death
domain-deficient mice die during mid-gestational stages.45,46
One report used zVAD and described a protective effect for
caspase inhibition in renal IRI, but the authors do not
provide data concerning the standard Periodic acid–Schiff
staining for evaluation and quantification of renal damage or
data for the serum levels of creatinine.38 Furthermore, for the
detection of apoptosis, TUNEL assays were performed that
have been demonstrated to lack specificity when different cell
death pathways are compared.47 However, in our experi-
ments, the same dose of zVAD did not reduce the serum
levels of urea and creatinine and did not prevent organ
damage (Figure 7). The incongruence might partly be
explained by the different timing of the zVAD application.
In addition to death receptor–mediated extrinsic apopto-
sis, it has been suggested that the pathophysiology of renal
IRI involves intrinsic apoptotic pathway activation as a
consequence of cytochrome c release, caspase-9 cleavage, and
Apaf-1 recruitment, which result in the formation of the
apoptosome,48 but to the best of our knowledge neither
Apaf-1- nor caspase-9-deficient mice have been investigated
in renal IRI. Our data concerning zVAD indicate that
intrinsic apoptosis does not significantly contribute to the
observed increase in serum levels of urea or creatinine or
renal organ damage. Undoubtedly, there is an apoptotic
component in the pathophysiological course of renal IRI that
still might contribute to organ damage, but our data indicate
a functional predominance of necroptosis over apoptosis in
the deterioration of acute ischemic kidney failure.
Besides apoptosis and necroptosis, other types of PCD are
likely to be involved, as even with high doses of Nec-1,
substantial renal tubular damage was detected, although the
serum levels of urea and creatinine were low (Figure 6). An
obvious example is the release of apoptosis-inducing factor
and the cleavage of poly [ADP-ribose] polymerase-1 upon
severe renal ischemia as a consequence of persistent MPT,
which leads to CICD in renal IRI.48 Similarly, genetic
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deficiency of the MPT pore (MPTP) regulator cyclophilin D
is well established to protect against renal IRI.49 In this
regard, it has been discussed that the formation of the
necroptosome might be an upstream event that results in
opening of the MPTP and the subsequent MPT.16 However,
at least in activated cyclophilin D/RIP3 double-deficient
T cells, this appears not to be the case.20
Given the protective effect of Nec-1 and the finding
that TNFR1-deficient mice are not protected from renal
IRI,43 the most likely candidate to be responsible for death
receptor–mediated necroptosis is the Fas–FasL system.
Indeed, a recent report and our own unpublished observa-
tions indicate that inhibitory a-FasL monoclonal antibodies
(MFL3 or MFL4) efficiently protect mice from renal IRI.35
Because we demonstrate here that the apoptotic cascade is of
minor importance in renal IRI (Figure 7), it might be
speculated that FasL-mediated necroptosis is the deteriorat-
ing pathophysiological component, but data that support this
hypothesis are still lacking. However, we cannot rule out the
possibility of death receptor–independent activation of the
necroptosome under ischemic conditions, although in an
attempt to define cell death subroutines the Nomenclature
Committee on Cell Death suggested that necroptosis is death
receptor–mediated.47 Most studies on necroptosis have been
conducted in a setting that involves TNFR stimulation using
mouse fibroblast cell lines (L929 cells) that were stimulated
with TNF-a. However, receptor-independent Rip1-depen-
dent necroptosis has recently been reported, which might
result from the assembly of the so-called ripoptosome.50–52
This large 2MDa complex is capable of inducing both apop-
totic and necroptotic signals, but because Nec-1 does and
zVAD does not protect from renal IRI, only ripoptosome-
mediated necroptosis might be considered as a cause of renal
IRI. Therefore, further investigations are required to unravel
the precise characteristics of the necroptotic events in renal
IRI. Blocking IR-induced necroptosis might be relevant in
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Figure 7 |Renal ischemia/reperfusion injury (IRI) is predominated by necroptosis rather than apoptosis. Six- to eight-week-old male
C57BL/6N mice were left untreated or underwent 30min of bilateral renal pedicle clipping in the presence of 200 ml phosphate-buffered
saline, necrostatin-1 (Nec-1), or zVAD, as indicated. (a) Periodic acid-Schiff staining of representative renal histomicrographs is shown.
Bar¼ 20 mm. (b) Quantification of the renal damage score is illustrated for whole kidneys (black bars), the outer renal cortex (white bars),
and the medullary cortex (gray bars), as indicated. (c) Serum urea and (d) serum creatinine levels are depicted for all groups (n¼ 8 for
each group, Po0.02). *Po0.05.
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kidney transplantation to maintain initial graft function, but
also to avoid the triggers of acute and chronic rejection.
In conclusion, we describe both the presence and the func-
tional relevance of Rip1-dependent necroptosis in the patho-
physiology of renal IRI. Our results regarding the potency of
Nec-1 to specifically interrupt necroptotic signaling provide a
new strategy to prevent and treat ischemic kidney injury.
Above that, the recognition of necrosis as a regulated process
mandates reexamination of PCD in the kidney.
MATERIALS AND METHODS
Reagents and antibodies
The zVAD-fmk (herein referred to as zVAD), the ApoAlert annexin
V-FITC antibody, the mouse a-Fas antibody (clone Jo2), and the
mouse a-Rip1 antibody for western blotting were purchased from
BD Biosciences (Heidelberg, Germany). The human a-Fas antibody
(clone 7C11) was purchased from Immunotech (Marseille, France).
Purified murine TNF-a was obtained from BioLegend (Uithoorn,
the Netherlands). The reagents CHX and necrostatin-1 were
obtained from Sigma-Aldrich (Taufkirchen, Germany). The
inactive necrostatin-1–derivative Nec-1i was obtained from
Calbiochem (Darmstadt, Germany). The polyclonal antibody
against murine RIP3 was purchased from IMGENEX (Biomol,
Hamburg, Germany). The b-actin antibody was purchased
from Cell Signaling (Frankfurt, Germany), and the Rip1 antibody
for immunohistochemistry was purchased from Santa Cruz
(Heidelberg, Germany).
Cell culture
L929 fibrosarcoma cells and HT29 human adenocarcinoma cells
were originally obtained from ATCC (Manassas, VA). L929 cells
were cultured in Dulbecco’s modified Eagle’s medium (Invitrogen,
Darmstadt, Germany) supplemented with 10% fetal calf serum
(FCS) and penicillin-streptomycin. HT29 cells were maintained in
Minimum essential medium with Earle’s salts (Invitrogen), 10% FCS
with glutamine, penicillin-streptomycin, nonessential amino acids,
and sodium pyruvate. TKPTS cells were published previously53
and were a kind gift from Bello-Reuss and Megyesi. TKPTS cells
were cultured in Dulbecco’s modified Eagle’s medium/Ham’s F12
medium with glutamine supplemented with SITE liquid media
(Sigma-Aldrich), 15mmol/l HEPES, 7% FCS, and penicillin-
streptomycin. The murine mesangial cell line MMC was cultured
in Dulbecco’s modified Eagle’s medium supplemented with 10%
FCS, 63U of bovine insulin (Sigma-Aldrich) per 500ml medium,
and penicillin-streptomycin. The murine glomerular epithelial cell
line glENDp54 was cultured in RPMI 1640 containing 10% FCS and
penicillin-streptomycin. All cell lines were cultured in a humidified
5% CO2 atmosphere.
Assessment of cell death
Phosphatidylserine exposure to the outer cell membrane was
quantified by annexin V staining followed by fluorescence-activated
cell sorting analysis. Cells were stimulated for the indicated times
at 371C with 100 ng/ml TNF-a, 2mg/ml CHX, 30 mmol/l Nec-1,
or 25 mmol/l zVAD as indicated. Annexin V staining was performed
according to the manufacturer’s instructions. Fluorescence was
analyzed using an EPICS XL (Beckman Coulter, Krefeld, Germany)
flow cytometer. Data were analyzed using the EPICS System II
software.
Induction of renal IRI
For all IRI experiments, 6- to 8-week-old male C57BL/6N mice
(Charles River, Sulzfeld, Germany) were used. All in vivo experi-
ments were conducted according to the protocols approved by
the Protection of Animals Act. Induction of kidney IRI was per-
formed as described previously.54 Briefly, we performed a midline
abdominal incision and a bilateral renal pedicle clipping for 30min
using microaneurysm clamps (Aesculab, Tuttlingen, Germany).
Throughout the surgical procedure, the body temperature was
maintained between 35 and 37.51C by continuous monitoring using
a temperature-controlled self-regulated heating system (Fine Science
Tools, Heidelberg, Germany). After removal of the clamps, reper-
fusion of the kidneys was visually confirmed. The abdomen was closed
in two layers using standard 6–0 sutures. Sham-operated mice received
identical surgical procedures, except that microaneurysm clamps were
not applied. To maintain fluid balance, all of the mice were supple-
mented with 1ml of prewarmed phosphate-buffered saline adminis-
tered intraperitoneally directly after surgery. The mice were killed 48h
after reperfusion if not otherwise specified for each experiment.
Isolation of renal prox. tubule and thick ascending limb
segments
For detection of RIP expression, animals were killed 15min after
ischemia, followed by kidney isolation and enzymatic digestion.
Sorting of prox. tubules and thick ascending limb segments
according to their shape and morphology was performed at 41C
using a dissection microscope (Leica MZ16, Solms, Germany) in the
presence of 1mg/ml albumin as described previously.37
Histology, immunohistochemistry, and electron microscopy
Organs were dissected as indicated in each experiment and infused
with 4% neutral-buffered formaldehyde, fixated for 48 h, dehydrated
in a graded ethanol series and xylene, and finally embedded
in paraffin. Paraffin sections (3–5 mm) were stained with periodic
acid–Schiff reagent, according to the standard routine protocol.
Immunohistochemistry for Rip1 was performed as described
previously at a dilution of 1:500.36 Stained sections were analyzed
using an Axio Imager microscope (Zeiss, Oberkochen, Germany) at
 400 original magnification. Micrographs were digitalized using an
AxioCam MRm Rev. 3 FireWire camera and AxioVision Rel. 4.5
software (Zeiss). Organ damage was quantified by an experienced
pathologist in a double-blind manner on a scale ranging from
0 (unaffected tissue) to 10 (severe organ damage).
For ultrastructural analysis by electron microscopy, kidneys
were dissected into small samples (1mm sized), fixed in 2.5%
glutaraldehyde in 0.1mol/l sodium cacodylate (pH 7.4) at 41C
overnight, and postfixed for 4 h in buffered 1% osmium tetroxide on
ice. After rinsing with 0.1mol/l sodium cacodylate (pH 7.4),
specimens were dehydrated in a graded series of ethanol and
embedded in LR White resin (London Resin Company, Reading,
UK). Polymerization was achieved in gelatin capsules at 601C
for 48 h. Ultrathin sections of the specimens were cut with a
diamond knife on a Leica Ultracut UCT ultramicrotome and
placed on formvar-coated copper grids. Sections were stained with
uranyl acetate and lead citrate and analyzed using a Philips
CM10 TEM (Amsterdam, The Netherlands).
Statistical analysis
For all experiments, differences of data sets were considered statis-
tically significant when P-values were lower than 0.05, if not
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otherwise specified. Statistical comparisons were made using the
two-tailed Student’s t-test. Asterisks are used throughout the
manuscript to specify statistical significance in comparison
with the TCZ-treated groups (Figure 2 and 3b) or the IRI groups
(Figure 5–7).
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